Tuesday, January 25, 2011

Report from Biomedical Optics Symposium (BiOS)/Photonics West--Part 2

Even though it most definitely exists, “the cost benefit of most clinical biophotonics technology is not well documented,” said Brian C. Wilson (Department of Medical Biophysics, University of Toronto) in his informative presentation during Monday's Lasers and Photonics Marketplace Seminar.

Even though it most definitely exists, “the cost benefit of most clinical biophotonics technology is not well documented,” said Brian C. Wilson (Department of Medical Biophysics, University of Toronto) in his informative presentation during Monday's Lasers and Photonics Marketplace Seminar.

On Tuesday, two plenary sessions took place: Frances S. Ligler, the Navy’s Senior Scientist for Biosensors and Biomaterials and current Chair of the Bioengineering Section of the National Academy of Engineering, presented a Perspective on the Future of Optical Biosensors. And Harold G. Craighead, Director of the Nanobiotechnology Center at Cornell University, explored the use of nanostructures for biological research.

No comments: